PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Used as a weight loss agent; some reviews suggest weight loss and athletic performance may be only modestly improved for short durations [PMID:31644021, PMID:15040625].
In a rat model of bleomycin-induced idiopathic pulmonary fibrosis, Ephedra demonstrated significantly reduced alveolitis and pulmonary fibrosis grades compared to a model group [PMID:24854661].
Ma-Huang-Fu-Zi-Xi-Xin decoction has been evaluated for treatment effects and safety in patients with allergic rhinitis [PMID:29636787].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 36479472 (2022) — Dietary supplements for obesity. · Journal of preventive medicine and hygiene
- 2.PMID: 31644021 (2012) — Herb-induced liver injury: Systematic review and meta-analysis. · World journal of clinical cases
- 3.PMID: 10948380 (2000) — Hepatotoxicity of botanicals. · Public health nutrition
- 4.PMID: 12108613 (2002) — Ma huang toxicity. · Mayo Clinic proceedings
- 5.PMID: 12916063 (2003) — Ephedra in perspective--a current review. · Phytotherapy research : PTR
- 6.